<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=The_Latest_Selinexor_Is_Twice_The_Fun</id>
		<title>The Latest Selinexor Is Twice The Fun - Історія редагувань</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=The_Latest_Selinexor_Is_Twice_The_Fun"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=The_Latest_Selinexor_Is_Twice_The_Fun&amp;action=history"/>
		<updated>2026-05-04T03:33:56Z</updated>
		<subtitle>Історія редагувань цієї сторінки в вікі</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=The_Latest_Selinexor_Is_Twice_The_Fun&amp;diff=115360&amp;oldid=prev</id>
		<title>Mittenedge34: Створена сторінка: Forty percent of the female patients had been on hemodialysis treatment for 36 months. Corresponding figures for the male patients were 43.1 and 27.8%, respecti...</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=The_Latest_Selinexor_Is_Twice_The_Fun&amp;diff=115360&amp;oldid=prev"/>
				<updated>2016-11-20T20:28:58Z</updated>
		
		<summary type="html">&lt;p&gt;Створена сторінка: Forty percent of the female patients had been on hemodialysis treatment for 36 months. Corresponding figures for the male patients were 43.1 and 27.8%, respecti...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Нова сторінка&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Forty percent of the female patients had been on hemodialysis treatment for 36 months. Corresponding figures for the male patients were 43.1 and 27.8%, respectively. Overall dialysis vintage did not reach statistical significance between the genders. There was only one female patient moving to PD modality from hemodialysis, whereas 144 (3.3%) males and 96 (2.9%) females were transplanted (P = 0.278). Dialysis practice AVF was used more frequently in males, whereas tunneled and untunneled catheters, and also AVG were used more frequently in females [http://www.selleckchem.com/products/rgfp966.html RGFP966] (Table?1). Usage of AVF was associated with more favorable outcome in both genders when compared with central catheters; however, statistical analysis revealed no survival difference in patients who had used AVF or AVG for vascular access (data not shown). Similar to the incident cases, Kt/V was significantly higher in females. In both genders, survival rate decreased with lower (1.4) Kt/V was associated with better outcome only in the females. IDWG/dry weight was 3.3 �� 1.4% in the females and 3.4 �� 1.3% in males, respectively (P  mmHg) and diastolic (73.5 �� 9.0 versus 76.6 �� 8.5 mmHg) blood [http://www.selleckchem.com/products/kpt-330.html Selinexor] pressures were lower in the females when compared with males (P [http://en.wikipedia.org/wiki/3-mercaptopyruvate_sulfurtransferase 3-mercaptopyruvate sulfurtransferase] was not the case for females. Laboratory parameters, and ESA and vitamin D usage Laboratory parameters are shown in Table?1. Univariate outcome statistics revealed the following findings: both genders were characterized by worse survival in patients with hemoglobin values below 9 g/dL. Hemoglobin values &amp;gt;13 g/dL were associated with worse survival in females, but better survival in males, when compared with the cases with hemoglobin between 11 and 12 g/dL. Lower serum phosphorus (5.5 mg/dL). Lower PTH values (585 pg/mL) PTH values were noted to have better survival. Serum albumin&lt;/div&gt;</summary>
		<author><name>Mittenedge34</name></author>	</entry>

	</feed>